The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial-Reference-Cited by-同舟云学术

The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial

Published:2016-08-11 Issue:1 Volume:17 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Bush Shirley Harvey,Lacaze-Masmonteil Nathalie,McNamara-Kilian Marie Theresa,MacDonald Alistair Richard,Tierney Sallyanne,Momoli Franco,Agar Meera,Currow David Christopher,Lawlor Peter Gerard

Funder

University of Ottawa

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-016-1525-8.pdf

Reference67 articles.

1. Bruera E, Miller L, McCallion J, Macmillan K, Krefting L, Hanson J. Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage. 1992;7:192–5.

2. Lawlor PG, Bruera ED. Delirium in patients with advanced cancer. Hematol Oncol Clin North Am. 2002;16:701–14.

3. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer. 1997;79:835–42.